Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01770743 · ClinicalTrials.gov registry record · Phase 2

A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels

A Phase 2 study of Anthrax, sponsored by Emergent BioSolutions.

Completed
Registry status
Phase 2
Development phase
168
Enrollment target
4
Study locations

NCT01770743 is a Phase 2 study of Anthrax that has completed, run by Emergent BioSolutions. The registered enrollment target is 168 participants, below the 750-participant average among 6 other Anthrax trials with a reported enrollment target (78% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01770743, a Phase 2 study of Anthrax, has completed, sponsored by Emergent BioSolutions.

COMPLETED
Registry status
Phase 2
Development phase
168 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to assess the safety and immunogenicity of an anthrax vaccine. The vaccine schedule and dose will also be assessed.

Conditions Studied

Anthrax

Interventions

  • BIOLOGICAL AV7909
  • BIOLOGICAL BioThrax

Study Locations (4)

Florida

  • Miami Research Associates - Miami

South Carolina

  • Costal Carolina Research - Mt. Pleasant

Texas

  • Central Texas Allergy and Asthma - New Braunfels

Utah

  • Jean Brown Research - Salt Lake City

Trial Details

FieldValue
Enrollment Target 168 participants
Start Date 2013-01
Est. Completion 2014-12
Phase Phase 2

Sponsor

Emergent BioSolutions

34 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01770743

The ClinicalTrials.gov registry entry for NCT01770743 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 750-participant average among 6 other Anthrax trials with a reported enrollment target (78% lower). The listed sponsor is Emergent BioSolutions, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anthrax appearing as the primary indexed condition, and to 2 interventions - of which AV7909 is the first listed.

NCT01770743 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Florida, South Carolina, Texas.

Frequently Asked Questions

What is clinical trial NCT01770743 about?

NCT01770743 is a clinical study titled "A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels". The purpose of this study is to assess the safety and immunogenicity of an anthrax vaccine. The vaccine schedule and dose will also be assessed.

What is the current status of trial NCT01770743?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 168 participants. The study started on 2013-01. Estimated completion is 2014-12.

What conditions does trial NCT01770743 study?

This clinical trial studies the following conditions: Anthrax.

What interventions are being tested in trial NCT01770743?

The interventions under investigation include: AV7909 (BIOLOGICAL), BioThrax (BIOLOGICAL).

Who is sponsoring clinical trial NCT01770743?

This trial is sponsored by Emergent BioSolutions, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01770743 being conducted?

This trial has 4 study locations across Florida, South Carolina, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Anthrax

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Anthrax

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.